| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +79.1K | 99.7% | $0.37 | +$29.5K |
| Sells | 1 | -240 | 0.3% | $0.18 | -$42 |
| Net | +1 | +78.9K | 99.4% | +$29.5K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Eric A. Adams | President & CEO, Director | $15.8K | +$14.9K | +1764% | May 27, 2024 |
| Andrew Hull | Director | $14.9K | +$14.6K | +4941% | Feb 21, 2024 |
| Bruce Colwill | Cfo | $10.3K | Jan 24, 2022 | ||
| Alexandra Diane Janet Mancini | Consultant | $0 | -$42 | -100% | Jul 31, 2024 |
| Michael Woudenberg | Chief Operating Officer | May 27, 2024 | |||
| Shane Johnson | Sr VP & General Manager | Dec 23, 2023 | |||
| Bryan Baldasare | Director | Dec 23, 2023 | |||
| Sarah Li | VP Accounting & Controller | Dec 16, 2022 | |||
| Jonathan Tegge | Interim CFO | Dec 23, 2023 | |||
| William J. Garner | Director | Jan 24, 2022 | |||
| Nicole Lemerond | Director | Dec 23, 2023 | |||
| Janet Grove | Director | Dec 23, 2023 | |||
| Netta Jagpal | Chief Financial Officer | Feb 20, 2024 | |||
| Brenda Edwards | Interim CFO | Apr 1, 2022 | |||
| Catherine Sazdanoff | Director | Dec 29, 2021 | |||
| Adam D. Cutler | Director | Jan 24, 2022 | |||
| Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | May 27, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|